Skip to main content
. 2012 Jan 18;81(7):698–706. doi: 10.1038/ki.2011.444

Figure 3.

Figure 3

Adjusted hazard ratios for the composite outcome of glomerular filtration rate event or end-stage renal disease among age, race, HbA1c, and renin–angiotensin–aldosterone system blockade subgroups. Hazard ratios greater than 1 demonstrate an increased risk for composite outcome with sulfonylurea compared with metformin. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.